Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.4367
+0.0351 (8.74%)
At close: May 30, 2025, 4:00 PM
0.4470
+0.0103 (2.36%)
After-hours: May 30, 2025, 4:47 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $129.33 million as of May 30, 2025. Its market cap has decreased by -78.86% in one year.
Market Cap
129.33M
Enterprise Value
-150.13M
1-Year Change
-78.86%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $129.33M, a decrease of -96.87%. That is a compound annual growth rate of -58.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 118.94M | -36.39% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |